Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

NanoSTRING nCounter Human tumor Signaling 360 Panel for xenograft tumor tissue

ABSTRACT: Whether Wnt signaling-targeted genes and co-receptors were downregulated in STP1002 (TNKSi)-treated tumor tissues,

ORGANISM(S): Homo sapiens

PROVIDER: GSE197963 | GEO | 2022/03/09

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

NanoSTRING nCounter Mouse Tumor Signaling 360 Panel for mouse ileum tissue

Project description:Whether Wnt signaling-targeted genes and co-receptors were downregulated in STP1002 (TNKSi)-treated ileum tissues.

2022-03-13 | GSE198140 | GEO

NanoString Human PC3 nCounter PanCancer IO 360 panel

Project description:The goal of this study was to investigate the roles of Butyrophilin Subfamily 1 Member A1 (BTN1A1) in terms of the signaling pathway after overexpression of BTN1A1A1 gene. To this end, we conducted NanoString analysis. From NanoString analysis with BTN1A1-overexpressing PC3 cells, we concluded that BTN1A1 play a pivotal role in the regulation of several signaling pathway including Jak-STAT pathway that is involved in processes such as immunity, cell division, cell death and tumor formation.

2021-10-19 | GSE186060 | GEO

NanoSTRING nCounter Human tumor Signaling 360 Panel for xenograft tumor tissue

Project description:NanoSTRING nCounter Human tumor Signaling 360 Panel for xenograft tumor tissue

| PRJNA812948 | ENA

NanoString Human PC3 nCounter PanCancer IO 360 panel

Project description:NanoString Human PC3 nCounter PanCancer IO 360 panel

| PRJNA772256 | ENA

NanoSTRING nCounter Mouse Tumor Signaling 360 Panel for mouse ileum tissue

Project description:NanoSTRING nCounter Mouse Tumor Signaling 360 Panel for mouse ileum tissue

| PRJNA813853 | ENA

nCounter NanoString Human Immunology V2 panel

Project description:mRNA expression in human bronchial epithelial cells unstimulated was compared with mRNA expression of cells stimulated with poly (I:C) (viral mimic) and poly (I:C) in combination with imiquimod (TLR7 agonist; Treatment). The aim was to assess the effect of imiquimod treatment on poly (I:C)-dependent changes in bronchial epithelium from asthmatics.

2021-08-02 | GSE181281 | GEO

Nanostring ncounter NHP Immunology V2 panel

Project description:The gene expression analysis of the RNA samples were analyzed with NanoString Non Human Primate immunology panel comprised of 754 immune related gene

2021-12-25 | GSE192584 | GEO

Easy NanoString nCounter data analysis with the NanoTube.

Project description:SummaryThe NanoTube is an open-source pipeline that simplifies the processing, quality control, normalization and analysis of NanoString nCounter gene expression data. It is implemented in an extensible R library, which performs a variety of gene expression analysis techniques and contains additional functions for integration with other R libraries performing advanced NanoString analysis techniques. Additionally, the NanoTube web application is available as a simple tool for researchers without programming expertise.Availability and implementationThe NanoTube R package is available on Bioconductor under the GPL-3 license (https://www.bioconductor.org/packages/NanoTube/). The R-Shiny application can be downloaded at https://github.com/calebclass/Shiny-NanoTube, or a simplified version of this application can be run on all major browsers, at https://research.butler.edu/nanotube/.Supplementary informationSupplementary data are available at Bioinformatics online.

| S-EPMC9805552 | biostudies-literature

Identification of response signatures for tankyrase inhibitor treatment in tumor cell lines

Project description:Small-molecule tankyrase 1 and tankyrase 2 (TNKS1/2) inhibitors are effective anti-tumor agents in selected tumor cell lines and mouse models. Here, we characterized the response signatures and the in-depth mechanisms for the anti-proliferative effect of tankyrase inhibition (TNKSi). The TNKS1/2-specific inhibitor G007-LK was used to screen 537 human tumor cell lines and a panel of in particular TNKSi-sensitive tumor cell lines was identified. Transcriptome, proteome and bioinformatic analyses revealed the overall TNKSi-induced response signatures in the selected panel. TNKSi-mediated inhibition of WNT/β-catenin, YAP and PI3K/AKT signaling was validated and correlated with lost expression of the key oncogene MYC and impaired cell growth. Moreover, we show that TNKSi induces accumulation of TNKS1/2-containing β-catenin degradasomes functioning as central complexes interacting with YAP and AMOT proteins during attenuation of YAP signaling. These findings provide a contextual and mechanistic framework for using TNKSi in anti-cancer treatment that warrants further comprehensive preclinical and clinical evaluations.

2021-09-09 | PXD022908 | Pride

Identification of response signatures for tankyrase inhibitor treatment in tumor cell lines

Project description:Anti-cancer treatment, using small-molecule tankyrase 1 and tankyrase 2 (TNKS1/2) inhibition (TNKSi) shows effect against selected tumor cell lines and in mouse models. Here, we characterize the responsiveness signatures and in depth mechanisms for the anti-proliferative effect of TNKSi. The TNKS1/2-specific inhibitor G007-LK was screened against 537 human tumor cell lines, and a panel of in particular TNKSi-sensitive tumor cell lines was identified. Transcriptome, proteome and bioinformatic analyses classified the overall TNKSi-induced response signatures in the selected panel. Prediction of TNKSi-mediated inhibition of WNT/β-catenin, YAP and PI3K/AKT signaling was validated and correlated with lost expression of the key oncogene MYC and impaired cell growth. Moreover, we show that TNKSi, when attenuating YAP signaling, induces accumulation of TNKS1/2-containing β-catenin degradosomes functioning as central complexes interacting with YAP and AMOT proteins. The findings provide a contextual and mechanistic framework for TNKSi in cancer cell lines rationalizing further comprehensive preclinical and clinical evaluations.

2021-06-18 | GSE162648 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data